Author: Kelly J. Clark, MD

New Health Department Guidelines May Curb Stigma of Medication for Addiction Treatment

by Kelly J. Clark, MD | Apr 23, 2018

Recently, the Substance Abuse and Mental Health Administration (SAMHSA), a division of the U.S. Department of Health and Human Services, made an important recommendation that will impact anyone who works in the field of opioid addiction. By extension, anyone who is treated for opioid addiction is also affected by this breakthrough information.

Read More

The Facts About Medication Treatment for Opioid Addiction

by Kelly J. Clark, MD | Mar 6, 2018

As the opioid epidemic devastates every corner of this country, there’s a reason that medication-assisted treatment (MAT) has been getting more and more attention by the media and policymakers:  

It works.

But misunderstandings around MAT persist. This starts with the term MAT itself, based on the idea that medication is an assistance to other, primary forms of treatment for addiction, such as counseling. The Substance Abuse and Mental Health Services Administration recently clarified this view with a new recommendation stating that patients with opioid use disorder (OUD) should be given access to the three FDA-approved medications: methadone, buprenorphine or naltrexone. SAMHSA, which is part of the U.S. Health and Human Services Department, is clear on this point: “It is not sound medical practice to deny people with OUD access to FDA-approved medications for their illness.”

Read More

Get Help Now

If you or someone you know suffers from the disease of addiction, please call 833-505-HOPE to speak with a professional.

Recent Posts